Get Flat 15% Discount on ED Drugs for orders value $70 or more
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      India`s Strides Arcolab gets USFDA nod for HIV tablets


      Mumbai (ANTARA News/Asia Pulse) -- Indian pharmaceutical firm Strides Arcolab (BSE:532531) on Wednesday said it has received the nod from the United States Food and Drug Administration (USFDA) for a dose combination of Lamivudine and Stavudine tablets used to treat adults and children who are infected with HIV.

      It has received approval from the USFDA for one new drug application for a fixed dose combination of Lamivudine and Stavudine tablets, Strides Arcolab said in a filing to the Bombay Stock Exchange.

      "This approval is yet another significant milestone in the front line of approvals for HIV medicines. This, combined with our pipeline of second line drugs will makes us a significant player in the quality, affordable multi-source anti-retro virals (ARV)s business segment," chief executive officer of the Indian operations of Strides, V S Iyer, said.

      April 20, 2009


      Share this Article!

    Back to top^